30/12/2021
COVID-19 vaccine is effective in inflammatory bowel disease patients and is not associated with disease exacerbation
Clinical Gastroenterology and Hepatology 12.2021
04/11/2021
Mistakes in colonoscopic surveillance in IBD and how to avoid them
UEG Education, 2021 - Matthew D Rutter
01/10/2021
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
William J. Sandborn et al., NEJM September 30th, 2021
28/08/2021
Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn's Disease: Results From the VISIBLE 2 Randomised Trial
Séverine Vermeire, William J Sandborn et al. Journal of Crohn's and Colitis, 17 August 2021
04/08/2021
Comparative Efficacy for Infliximab vs. Vedolizumab in Biologic Naive Ulcerative Colitis
Neeraj Narula, MD, MPH, FRCPC, Jean-Frederic Colombel, MD, Walter Reinisch, MD, PhD Published CGH July 27, 2021 DOI:https://doi.org/10.1016/j.cgh.2021.07.038
03/07/2021
Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn’s Disease: Results from the Phase 2 Open-Label Extension Study
Journal of Crohn's and Colitis, 02 June 2021 Marc Ferrante, Brian G Feagan, et al.
05/06/2021
Ileal or Colonic Histologic Activity Is Not Associated With Clinical Relapse in Patients With Crohn’s Disease in Endoscopic Remission.
Clinical Gastroenterology and Hepatology June_2021 - Anne B. Hu, William Tan,Vikram Deshpande, and Ashwin N. Ananthakrishnan.
11/05/2021
STRIDE II An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
Gastroenterology, 04/2021
04/04/2021
Ultrasonography tight control and monitoring in Crohn’s disease during different biological therapies: a multicenter study
E. Calabrese, A. Rispo, F. Zorzi, E. De Cristofaro, A. Testa, G. Costantino, A. Viola, C. Bezzio, C. Ricci, S. Prencipe, C. Racchini, G. Stefanelli, M. Allocca, M. Cappello, G. Maconi, A. Spagnoli, G. Monteleone, F. Castiglione et al
03/03/2021
Five-year Efficacy and Safety of Ustekinumab Treatment in Crohn’s Disease: the IM-UNITI trial
Sandborn WJ, Rebuck R, Wang Y, Zou B, Adedokun OJ, Gasink C, Sands BE, Hanauer SB, Targan S, Ghosh S, de Villiers WJ, Colombel J-F, Feagan BG, Lynch JP. Clinical Gastroenterology and Hepatology (2021), doi: https://doi.org/10.1016/j.cgh.2021.02.025.
17/02/2021
Ustekinumab for Ulcerative colitis
Reena Khanna, MD, Waqqas Afif, MD. Gastroenterology (2021) https://doi.org/10.1053/j.gastro.2021.02.002.
28/01/2021
Incidence of and risk factors for colorectal strictures in ulcerative colitis: a multicenter study
Pierre-Antoine Laurain ∗ Laurent Peyrin-Biroulet. Clinical Gastroenterology and Hepatology January 21, 2021 - DOI: https://doi.org/10.1016/j.cgh.2021.01.028